Skip to content 
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota. more
| Time Frame | INSP | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | -9.25% | 0.72% | -1.31% |
| 1-Month Return | -34.46% | 1.27% | 0.78% |
| 3-Month Return | -25.93% | 3.13% | 3.46% |
| 6-Month Return | -29.93% | 15.81% | 6.19% |
| 1-Year Return | -65.63% | 8.89% | 11.68% |
| 3-Year Return | -76.62% | 20.79% | 71.21% |
| 5-Year Return | -72.37% | 35.89% | 74.81% |
| 10-Year Return | 147.8% | 138.44% | 256.59% |
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 233.39M | 407.86M | 624.80M | 802.80M | 911.98M | [{"date":"2021-12-31","value":25.59,"profit":true},{"date":"2022-12-31","value":44.72,"profit":true},{"date":"2023-12-31","value":68.51,"profit":true},{"date":"2024-12-31","value":88.03,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Cost of Revenue | 33.28M | 66.11M | 96.58M | 122.99M | 133.22M | [{"date":"2021-12-31","value":24.98,"profit":true},{"date":"2022-12-31","value":49.63,"profit":true},{"date":"2023-12-31","value":72.49,"profit":true},{"date":"2024-12-31","value":92.31,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Gross Profit | 200.12M | 341.74M | 528.22M | 679.82M | 778.76M | [{"date":"2021-12-31","value":25.7,"profit":true},{"date":"2022-12-31","value":43.88,"profit":true},{"date":"2023-12-31","value":67.83,"profit":true},{"date":"2024-12-31","value":87.3,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Gross Margin | 85.74% | 83.79% | 84.54% | 84.68% | 85.39% | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.72,"profit":true},{"date":"2023-12-31","value":98.6,"profit":true},{"date":"2024-12-31","value":98.76,"profit":true},{"date":"2025-12-31","value":99.59,"profit":true}] |
| Operating Expenses | 239.97M | 389.33M | 568.49M | 643.74M | 727.80M | [{"date":"2021-12-31","value":32.97,"profit":true},{"date":"2022-12-31","value":53.49,"profit":true},{"date":"2023-12-31","value":78.11,"profit":true},{"date":"2024-12-31","value":88.45,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Operating Income | (39.85M) | (47.59M) | (40.27M) | 36.08M | 50.95M | [{"date":"2021-12-31","value":-78.21,"profit":false},{"date":"2022-12-31","value":-93.4,"profit":false},{"date":"2023-12-31","value":-79.03,"profit":false},{"date":"2024-12-31","value":70.81,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Total Non-Operating Income/Expense | (4.12M) | 6.70M | 38.42M | 45.59M | 32.14M | [{"date":"2021-12-31","value":-9.04,"profit":false},{"date":"2022-12-31","value":14.69,"profit":true},{"date":"2023-12-31","value":84.27,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":70.49,"profit":true}] |
| Pre-Tax Income | (41.97M) | (44.27M) | (19.91M) | 58.45M | 65.70M | [{"date":"2021-12-31","value":-63.88,"profit":false},{"date":"2022-12-31","value":-67.38,"profit":false},{"date":"2023-12-31","value":-30.3,"profit":false},{"date":"2024-12-31","value":88.97,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Income Taxes | 72.00K | 613.00K | 1.25M | 4.94M | (79.72M) | [{"date":"2021-12-31","value":1.46,"profit":true},{"date":"2022-12-31","value":12.4,"profit":true},{"date":"2023-12-31","value":25.22,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":-1612.56,"profit":false}] |
| Income After Taxes | (42.04M) | (44.88M) | (21.15M) | 53.51M | 145.42M | [{"date":"2021-12-31","value":-28.91,"profit":false},{"date":"2022-12-31","value":-30.86,"profit":false},{"date":"2023-12-31","value":-14.55,"profit":false},{"date":"2024-12-31","value":36.8,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Income From Continuous Operations | (42.04M) | (44.88M) | (32.77M) | 53.51M | 145.42M | [{"date":"2021-12-31","value":-28.91,"profit":false},{"date":"2022-12-31","value":-30.86,"profit":false},{"date":"2023-12-31","value":-22.53,"profit":false},{"date":"2024-12-31","value":36.8,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Net Income | (42.04M) | (44.88M) | (21.15M) | 53.51M | 145.42M | [{"date":"2021-12-31","value":-28.91,"profit":false},{"date":"2022-12-31","value":-30.86,"profit":false},{"date":"2023-12-31","value":-14.55,"profit":false},{"date":"2024-12-31","value":36.8,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| EPS (Diluted) | (1.55) | (1.64) | (0.74) | 1.73 | 2.58 | [{"date":"2021-12-31","value":-60.08,"profit":false},{"date":"2022-12-31","value":-63.57,"profit":false},{"date":"2023-12-31","value":-28.68,"profit":false},{"date":"2024-12-31","value":67.05,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
| INSP | |
|---|---|
| Cash Ratio | 1.09 |
| Current Ratio | 6.08 |
| Quick Ratio | 4.56 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| INSP | |
|---|---|
| ROA (LTM) | 3.71% |
| ROE (LTM) | 19.77% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| INSP | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.14 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.86 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| INSP | |
|---|---|
| Trailing PE | 12.35 |
| Forward PE | 40.98 |
| P/S (TTM) | 1.92 |
| P/B | 2.19 |
| Price/FCF | 42 |
| EV/R | 1.57 |
| EV/Ebitda | 21.72 |
Inspire Medical Systems Inc (INSP) share price today is $61.9
Yes, Indians can buy shares of Inspire Medical Systems Inc (INSP) on Vested. To buy
Yes, you can purchase fractional shares of Inspire Medical Systems Inc (INSP) via the Vested app. You can start investing in Inspire Medical Systems Inc (INSP) with a minimum investment of $1.
You can invest in shares of Inspire Medical Systems Inc (INSP) via Vested in three simple steps:
The 52-week high price of Inspire Medical Systems Inc (INSP) is $197.75. The 52-week low price of Inspire Medical Systems Inc (INSP) is $53.11.
The price-to-earnings (P/E) ratio of Inspire Medical Systems Inc (INSP) is 12.3497
The price-to-book (P/B) ratio of Inspire Medical Systems Inc (INSP) is 2.19
The dividend yield of Inspire Medical Systems Inc (INSP) is 0.00%
The market capitalization of Inspire Medical Systems Inc (INSP) is $1.73B
The stock symbol (or ticker) of Inspire Medical Systems Inc is INSP
Consider the share price of Inspire Medical Systems Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Inspire Medical Systems Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Inspire Medical Systems Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Inspire Medical Systems Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Inspire Medical Systems Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Inspire Medical Systems Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
